Hepatitis D screening
|
Hepatitis D |
|
Diagnosis |
|
Treatment |
|
Hepatitis D screening On the Web |
|
American Roentgen Ray Society Images of Hepatitis D screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: João André Alves Silva, M.D. [2] Jolanta Marszalek, M.D. [3]
Overview
Screening
All patients with current or previous IV drug use history should be evaluated for hepatitis B. However, screening is not recommended in asymptomatic HBsAg positive patients. Preventive measures and screening may be applied in:
- HBsAg positive patients, who have acute or chronic hepatitis D. The follow-up procedures should be equal, regardless of co-infection status with hepatitis D
- Patients who have acute hepatitis B, are not HBsAg positive and who are IgM anti-HBc positive may be tested for HDV.
- Patients with positive HBsAg and/or HDV antibody should be alerted not to share items such as razors, eating or drinking utensils.
- Patients without immunity to the virus should be vaccinated.
The general population, without risk for HBV and /or HDV, does not need screening.
Attending to the life cycle of HDV, and the potential complications of infection with this virus, the following screening recommendations should be applied:
Blood products should also be screened for the presence of HDV and HBV, to prevent infection by blood transfusion and hemodialysis.[2]
References
- ↑ 1.0 1.1 Lok AS, McMahon BJ (2004). "[AASLD Practice Guidelines. Chronic hepatitis B: update of therapeutic guidelines]" (PDF). Romanian Journal of Gastroenterology. 13 (2): 150–4. PMID 15229781. Retrieved 2012-02-10. Unknown parameter
|month=ignored (help) - ↑ Hughes SA, Wedemeyer H, Harrison PM (2011). "Hepatitis delta virus". Lancet. 378 (9785): 73–85. doi:10.1016/S0140-6736(10)61931-9. PMID 21511329.